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Introduction
Natural Killer Cell activity has traditionally been assessed
by detecting the lysis of tumor cells in The Chromium
Release assay. This classic assay relies on radioactive labels,
is laborious, and requires substantial quantities of patient
blood. Moreover the Chromium Release assay provides
low signal to noise ratios. We have developed an assay
that can visualize individual target cells to detect cytolytic
activity within a high signal to noise range, without invol-
ving radioactivity, via high-throughput imaging. We also
developed a miniaturized version of this assay to measure
NK activity with one tenth of the blood needed for a
classic Chromium Release assay, and with less labor.
Methods
The assay we developed is based on the imaging of indivi-
dual fluorescence-labeled target cells. K562 tumor cells
were used as targets, and peripheral blood mononuclear
cells (PBMC) as effector cells. In addition to using inacti-
vated PBMC, we also used IL-2 stimulated PBMC as
effectors. When performing the assay in 96 well format,
the PBMC were plated in serial dilution between 500,000
and 7,500 cells per well with 5,000 target cells per well.
The Chromium Release assay was set up in parallel using
identical conditions. Four hours later, the number of viable
tumor cells was quantitated using a fluorescence capable
ImmunoSpot® Analyzer or the radioactivity released was
measured. In a miniaturized version, one tenth of effector
and target cells were plated in a Terasaki plate format.
Results
The target cell visualization and Chromium Release assay
in a 96-well format required the same number of cells and
the results were comparable to each other. However, the
signal to noise ratio was two orders of magnitudes higher
for the target cell visualization assay, and required about a
third of investigator’s time invested. While, expectedly,
percentage of killing for different donors was highly vari-
able, the assay was highly reproducible for cryopreserved
samples between multiple days. The assay results obtained
in Terasaki plates, miniaturizing the assay tenfold, paral-
leled those of the 96-well format.
Conclusion
We have demonstrated the feasibility of assessing NK
function in a non-radioactive, high-throughput capable
system which will benefit clinical immune monitoring.
Signal to noise performance of the assay outperforms
Chromium Release, as does the need for investigator
effort. The miniaturized Terasaki format version of the
assay should be of particular value when access to PBMC
is limited, such as in pediatric, geriatric, and immune defi-
cient populations.
Authors’ details
1Cellular Technology Ltd., Shaker Hts., USA. 2Pharmasan Labs Inc., USA.
Published: 6 November 2014
doi:10.1186/2051-1426-2-S3-P144
Cite this article as: Sundararaman et al.: Imaging-based, non-radioactive
measurements of natural killer cell activity provides comparable results
as classic chromium release assays but with fewer cells and less labor.
Journal for ImmunoTherapy of Cancer 2014 2(Suppl 3):P144.
1Cellular Technology Ltd., Shaker Hts., USA
Full list of author information is available at the end of the article
Sundararaman et al. Journal for ImmunoTherapy of Cancer 2014, 2(Suppl 3):P144
http://www.immunotherapyofcancer.org/content/2/S3/P144
© 2014 Sundararaman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
